Tagged with Global

Betting the Bottom Dollar on AI in Pricing & Market Access
Alzheimer’s: Is Lilly’s Donanemab Really a Game Changer?
Pfizer, Roche, Daiichi Bosses to Head IFPMA’s New CEO Leadership Team
Spain’s Esteve Turns to German Investors to Fuel Growth
Back to the Future? Global Pandemic Treaty Negotiations Rumble On
Top Biologics CDMOs 2023
Four Insights from Amgen CEO Bob Bradway
Top 20 Global Pharma Companies 2023
Astellas’ Peter Sandor on the Future of Immuno-Oncology
The Dual Challenge of Unbalanced Inventory Growth & Medicine Shortages
BIO2023: Biogen CEO Slams IRA and Talks M&A Opportunities
Health Security Equals National Security: Funding, Data Sharing & Global Cooperation Needed
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here